Institute for the Advancement of Multicultural & Minority Medicine
Atlanta Health Summit
June 25, 2005
The Hon. Louis Sullivan, MD, speaking on the need for more minority health professionals.
Emory University was the site of the Atlanta summit. “Good Health: Your Right! Your Choice!” brought together medical experts and advocates who share a commitment to IAMMM’s mission and goals. The summit, which focused on chronic diseases affecting minority communities, was cosponsored by Emory University School of Medicine, American Cancer Society, American Heart Association, Centers for Disease Control and Prevention, Delta Sigma Theta Sorority, Inc., Turner Broadcasting Company, and others. In his keynote address, the Hon. Louis Sullivan, MD, discussed the need to increase the number of minorities in the health professions. Dr. Beny Primm provided a historical overview of health disparities and strategies that health care professionals can use to advocate on behalf of their patients. A physician panel, which included Dr. Richard Allen Williams, IAMMM vice chair and founder of the Association of Black Cardiologists; Carlos Del Rio, MD, chief of medical service, Grady Memorial Hospital; and Daniel Blumenthal, MD, MPH, associate dean for community programs, Morehouse School of Medicine, examined health disparities that affect communities of color and strategies for how patients can play a role in advocating for quality care.
During a special session, panelists discussed how organizations can collaborate to address disparities. The panel included Garth Graham, MD, MPH, Deputy Assistant Secretary for Minority Health, U.S. Department of Health and Human Services; Sharon Petty, MD, GlaxoSmithKline, Laura Orosco, Aetna Health, Brenda Lankford, RN, PhD, National Council of Pastors’ Spouses.
Panelists discuss health prevention, from left to right: Lawrence Bryant, Morehouse College; Dr. Garth Graham, U.S. Dept. of Health & Human Services; Laura Orosco, Aetna Health, Inc.; Dr. Brenda Lankford, National Council of Pastors’ Spouses; Dr. Sharon Petty. GlaxoSmithKline; Nynikka Palmer, American Cancer Society
2003-2005 AnnuAl RepoRt